24 results
F-3
EX-1.2
CMMB
Chemomab Therapeutics Ltd
16 Oct 23
Shelf registration (foreign)
4:25pm
submission); and (G) has not, either voluntarily or involuntarily, initiated, conducted, or issued or caused to be initiated, conducted or issued, any recall
8-K/A
CMMB
Chemomab Therapeutics Ltd
14 Apr 21
UNAUDITED PRO FORMA Condensed COMBINED FINANCIAL STATEMENTS
11:50am
the market;
refusal to approve pending applications or supplements to approved applications that Chemomab submits;
recall of products;
fines
424B3
r3ulxn8
12 Feb 21
Prospectus supplement
12:05pm
S-4/A
cnp jzuvwvn
10 Feb 21
Registration of securities issued in business combination transactions (amended)
1:19pm
S-4
74w3d66me
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.9
yqjc1
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
10-K
nngyywh2booyz0xah
17 Mar 20
Annual report
5:27pm
20-F/A
h1bp96
24 Apr 19
Annual report (foreign) (amended)
5:19pm
424B4
njswbd0h
13 Feb 19
Prospectus supplement with pricing info
8:20am
F-1/A
tj7nwq
11 Feb 19
Registration statement (foreign) (amended)
9:52am
F-1/A
gzy dlbtozb83bq
8 Feb 19
Registration statement (foreign) (amended)
12:00am
F-1/A
3mit7qy26q cpdn
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1
h504o
7 Jan 19
Registration statement (foreign)
5:11pm
DRS/A
wmubpu qang7d
27 Nov 18
Draft registration statement (amended)
12:00am
DRS
r049k
28 Sep 18
Draft registration statement
12:00am